Correlation between p53 gene expression and tumor‐cell proliferation in oropharyngeal cancer
- 15 May 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 57 (4) , 458-462
- https://doi.org/10.1002/ijc.2910570403
Abstract
The aim of our study was to analyze the correlation between tumor‐cell kinetics measured in vivo and p53 gene expression in a series of 49 oropharyngeal cancers. The duration of the S phase (TS), the labelling index (LI) and the potential doubling time (Tpot) were obtained by flow‐cytometry measurements of a tumor biopsy obtained after i.v. injection of 200 mg bromode‐oxyuridine into patients. An adjacent section of the same samples was studied by immunohistochemistry for the detection of p53 protein. Over‐expression of the p53 protein, as defined by strong p53 immunostaining of tumor nuclei, was found in 23/49 of the samples. Aneuploid tumors showed a higher LI, a shorter Tpot and a higher proportion of p53 gene over‐expression. A significant correlation was seen between p53 over‐expression and short Tpots. Indeed 87.5% of the tumors with a very short Tpot (⩽ 3 days) had p53 over‐expression, as compared with 27% of tumors with a longer Tpot (>3 days). Our data strongly suggest that over‐expression of the p53 gene is associated with rapid tumor‐cell proliferation in this type of cancer.Keywords
This publication has 17 references indexed in Scilit:
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Overexpression of P53 in head and neck cancerHead & Neck, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 allelesCell, 1992
- p53 function and dysfunctionCell, 1992
- p53, guardian of the genomeNature, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variationsRadiotherapy and Oncology, 1988